Evaluation of the safety and efficacy of telmisartan and enalapril, with the potential addition of frusemide, in moderate-renal failure patients with mild-to-moderate hypertension

Evaluation of the safety and efficacy of telmisartan and enalapril, with the potential addition of frusemide, in moderate-renal failure patients with mild-to-moderate hypertension

The effect on renal function and efficacy of the angiotensin II AT 1 -receptor blocker (ARB), telmisartan, were compared with those of the angiotensin-converting enzyme inhibitor, enalapril, for the treatment of mild-to-moderate hypertension (diastolic blood pressure [DBP] 95—114 mmHg) in the presen...

Full description

Bibliographic Details
Main Authors: Thierry Hannedouche, Jacques Chanard, Bertrand Baumelou, French Collaborative Telmisartan Study Group
Format: Article
Language:English
Published: Hindawi - SAGE Publishing 2001-12-01
Series:Journal of the Renin-Angiotensin-Aldosterone System
Online Access:https://doi.org/10.3317/jraas.2001.039

Internet

https://doi.org/10.3317/jraas.2001.039

Similar Items